The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome
Open accessAbstract
Mice with a targeted disruption of the gene encoding a lymphoid-expressed orphan G protein-coupled receptor, G2A, demonstrate a normal pattern of T and B lineage differentiation through young adulthood. As G2A-deficient animals age, they develop secondary lymphoid organ enlargement associated with abnormal expansion of both T and B lymphocytes. Older G2A-deficient mice (>1 year) develop a slowly progressive wasting syndrome, characterized by lymphocytic infiltration into various tissues, glomerular immune complex deposition, and anti-nuclear autoantibodies. G2A-deficient T cells are hyperresponsive to TCR stimulation, exhibiting enhanced proliferation and a lower threshold for activation. Our findings demonstrate that G2A plays a critical role in controlling peripheral lymphocyte homeostasis and that its ablation results in the development of a novel, late-onset autoimmune syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, autoimmunity has been observed in mice in which phagocytes lack the G-protein coupled receptor G2A41, which is required for the response to lysophosphatidylcholine 42”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [42]
Citations
Cites
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418
Chemokines and Cell Migration in Secondary Lymphoid Organs
Cyster, J. G. (1999) · Science · doi:10.1126/science.286.5447.2098 · Cited by 1,029
Gorelik, L., & Flavell, R. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80170-3 · Cited by 959
Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off
Parijs, L. V., & Abbas, A. K. (1998) · Science · doi:10.1126/science.280.5361.243 · Cited by 958
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 936
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Bachmaier, K., Krawczyk, C. M., Kozieradzki, I., Kong, Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A. C., Itié, A., et al. (2000) · Nature · doi:10.1038/35003228 · Cited by 674
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K. E., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E. M., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 626
Defective T Cell Differentiation in the Absence of Jnk1
Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J., & Flavell, R. A. (1998) · Science · doi:10.1126/science.282.5396.2092 · Cited by 579
Cited by
Sorted by citations
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,225
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue‐Kitano, R., & Igarashi, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,063
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 924
Martin, F., & Kearney, J. F. (2002) · Nature reviews. Immunology · doi:10.1038/nri799 · Cited by 867
Lysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. J. M. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
Anatomical Profiling of G Protein-Coupled Receptor Expression
Regard, J. B., Sato, I. T., & Coughlin, S. R. (2008) · Cell · doi:10.1016/j.cell.2008.08.040 · Cited by 704
Laulagnier, K., Motta, C., Hamdi, S. M., Sébastien, R. O. Y., Fauvelle, F., Pageaux, J., Kobayashi, T., Salles, J., Perret, B., Bonnerot, C., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031594 · Cited by 651
A Novel Host-Parasite Lipid Cross-talk
van der Kleij, D., Latz, E., Brouwers, J. F. H. M., Kruize, Y. C. M., Schmitz, M., Kurt-Jones, E. A., Espevik, T., de Jong, E. C., Kapsenberg, M. L., Golenbock, D. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206941200 · Cited by 587
Lauber, K., Blumenthal, S. G., Waibel, M., & Wesselborg, S. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00237-0 · Cited by 571
Clearance of apoptotic cells: implications in health and disease
Elliott, M. R., & Ravichandran, K. S. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201004096 · Cited by 568
Lysophospholipids--Receptor Revelations
Hla, T., Lee, M.-J., Ancellin, N., Paik, J. H., & Kluk, M. (2001) · Science · doi:10.1126/science.1065323 · Cited by 537
Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis
Chen, P., Zuo, H., Xiong, H., Kolar, M. J., Chu, Q., Saghatelian, A., Siegwart, D. J., & Wan, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614035114 · Cited by 530
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., et al. (2017) · Nature · doi:10.1038/nature23874 · Cited by 500
Aire deficient mice develop multiple features of APECED phenotype and show altered immune response
Ramsey, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.397 · Cited by 466
Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses
Elliott, M. R., Koster, K. M., & Murphy, P. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601520 · Cited by 440
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
zu Heringdorf, D. M., & Jakobs, K. H. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.026 · Cited by 393
Acidic tumor microenvironment and pH-sensing G protein-coupled receptors
Justus, C. R., Dong, L., & Yang, L. V. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00354 · Cited by 378
Metabolism and atherogenic disease association of lysophosphatidylcholine
Schmitz, G., & Ruebsaamen, K. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.029 · Cited by 358
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Drobnik, W., Liebisch, G., Audebert, F., Fröhlich, D., Glück, T., Vogel, P. M., Rothe, G., & Schmitz, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200401-jlr200 · Cited by 350
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A. M., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 343
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
Self-citationRetractedThe clearance of dying cells: table for two
Green, D. R., Oguin, T. H., & Martinez, J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.172 · Cited by 314
Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2A
Peter, C., Waibel, M., Radu, C. G., Yang, L. V., Witte, O. N., Schulze-Osthoff, K., Wesselborg, S., & Lauber, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706586200 · Cited by 258
Self-citationG2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine
Murakami, N., Yokomizo, T., Okuno, T., & Shimizu, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406561200 · Cited by 253
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes
Sevastou, I. G., Kaffe, E., Mouratis, M.-A., & Aidinis, V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.019 · Cited by 250
Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L., & Witte, O. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409415102 · Cited by 213
Self-citationXu, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00140-3 · Cited by 213
T cell chemotaxis to lysophosphatidylcholine through the G2A receptor
Radu, C. G., Yang, L. V., Riedinger, M., Au, M., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536801100 · Cited by 211
Self-citationCohen, L. J., Kang, H., Chu, J., Huang, Y.-H., Gordon, E. A., Reddy, B. V. B., Ternei, M. A., Craig, J. W., & Brady, S. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508737112 · Cited by 208
Radu, C. G., Shu, C. J., Nair‐Gill, E., Shelly, S. M., Barrio, J. R., Satyamurthy, N., Phelps, M. E., & Witte, O. N. (2008) · Nature Medicine · doi:10.1038/nm1724 · Cited by 202
Self-citationMedina, C. B., & Ravichandran, K. S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.13 · Cited by 199
Xin, L., Ide, H., Kim, Y. H., Dubey, P., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734139100 · Cited by 195
Self-citationTomura, H., Mogi, C., Sato, K., & Okajima, F. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.002 · Cited by 191
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Lauber, K., Ernst, A., Orth, M., i, M. H., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 200
Obinata, H., Hattori, T., Nakane, S., Tatei, K., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507787200 · Cited by 185
Lysophospholipids and their G protein-coupled receptors in inflammation and immunity
Gräler, M. H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00152-x · Cited by 181
Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A
Yang, L. V., Radu, C. G., Wang, L., Riedinger, M., & Witte, O. N. (2004) · Blood · doi:10.1182/blood-2004-05-1916 · Cited by 179
Self-citationLsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses
Girkontaitė, I., Missy, K., Sakk, V., Harenberg, A., Tedford, K., Pötzel, T., Pfeffer, K., & Fischer, K. (2001) · Nature Immunology · doi:10.1038/ni0901-855 · Cited by 161
RGS2: a multifunctional regulator of G-protein signaling
Kehrl, J. H. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00141-8 · Cited by 156
Emerging roles for lysophosphatidylserine in resolution of inflammation
Frasch, S. C., & Bratton, D. L. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.03.001 · Cited by 152
Negative Regulation of NF-κB Signaling by PIAS1
Liu, B., Yang, R., Wong, K. A., Getman, C., Stein, N., Teitell, M. A., Cheng, G., Wu, H., & Shuai, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1113-1123.2005 · Cited by 150
Macrophages are metabolically heterogeneous within the tumor microenvironment
Geeraerts, X., Fernández-García, J., Hartmann, F. J., de Goede, K. E., Martens, L., Elkrim, Y., Debraekeleer, A., Stijlemans, B., Vandekeere, A., Rinaldi, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110171 · Cited by 151
G2A and LPC: Regulatory functions in immunity
Kabarowski, J. H. S. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.007 · Cited by 144
Self-citationSystemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
Mizukami, H., Mi, Y.-D., Wada, R., Kono, M., Yamashita, T., Liu, Y.-J., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14530 · Cited by 153
Lin, P., & Ye, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209101200 · Cited by 132
Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells
Peter, C., Wesselborg, S., i, M. H., & Lauber, K. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0472-1 · Cited by 136
Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
Mizukami, H., Mi, Y., Wada, R., Kono, M., Yamashita, T., Liu, Y., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214530 · Cited by 125
Chemistry and biology of sphingolipids
Liao, J., Tao, J., Lin, G., & Liu, D. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.02.075 · Cited by 117
Lysophosphatidylcholine as a ligand for immunoregulation
Kabarowski, J. H. S., Xu, Y., & Witte, O. N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01179-6 · Cited by 116
Self-citationHattori, T., Obinata, H., Ogawa, A., Kishi, M., Tatei, K., Ishikawa, O., & Izumi, T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701172 · Cited by 116
Frasch, S. C., Berry, K. A. Z., Fernandez-Boyanapalli, R. F., Jin, H.-S., Leslie, C. C., Henson, P. M., Murphy, R. C., & Bratton, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807047200 · Cited by 114
Silliman, C. C., Elzi, D. J., Ambruso, D. R., Musters, R. J. P., Hamiel, C. R., Harbeck, R. J., Paterson, A. J., Bjornsen, A. J., Wyman, T. H., Kelher, M. R., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0402179 · Cited by 110
Li, H., Wang, D., Singh, L. S., Berk, M. P., Tan, H., Zhao, Z., Steinmetz, R. W., Kirmani, K., Wei, G., & Xu, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005705 · Cited by 108
Proton-Sensing GPCRs in Health and Disease
Sisignano, M., Fischer, M. J. M., & Geißlinger, G. (2021) · Cells · doi:10.3390/cells10082050 · Cited by 104
Tomura, H., Wang, J.-Q., Komachi, M., Damirin, A., Mogi, C., Tobo, M., Kon, J., Misawa, N., Sato, K., & Okajima, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505287200 · Cited by 103
Frasch, S. C., Fernandez-Boyanapalli, R. F., Berry, K. A. Z., Leslie, C. C., Bonventre, J. V., Murphy, R. C., Henson, P. M., & Bratton, D. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181800 · Cited by 102
The role of IgM antibodies in the recognition and clearance of apoptotic cells
Peng, Y., Kowalewski, R., Kim, S., & Elkon, K. B. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.045 · Cited by 100
Frasch, S. C., Berry, K. A. Z., Murphy, R. C., Borregaard, N., Henson, P. M., & Bratton, D. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6540 · Cited by 94
Kono, D. H., & Theofilopoulos, A. N. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0030-7 · Cited by 88
Wang, L., Radu, C. G., Yang, L. V., Bentolila, L. A., Riedinger, M., & Witte, O. N. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1044 · Cited by 88
Self-citationG2A as a receptor for oxidized free fatty acids
Obinata, H., & Izumi, T. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.11.002 · Cited by 84
Kostenis, E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20092 · Cited by 83
Effects of adjuvants on IgG subclasses elicited by virus-like Particles
Visciano, M. L., Tagliamonte, M., Tornesello, M. L., Buonaguro, L., & Buonaguro, L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-4 · Cited by 82
Natural product discovery from the human microbiome
Wilson, M. R., Zha, L., & Balskus, E. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.762906 · Cited by 78
G2A Deficiency in Mice Promotes Macrophage Activation and Atherosclerosis
Bolick, D. T., Skaflen, M. D., Johnson, L. E., Kwon, S., Howatt, D. A., Daugherty, A., Ravichandran, K. S., & Hedrick, C. C. (2008) · Circulation Research · doi:10.1161/circresaha.108.181131 · Cited by 78
Girkontaitė, I., Sakk, V., Wagner, M., Borggrefe, T., Tedford, K., Chun, J. J. M., & Fischer, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041483 · Cited by 79
Park, D. W., Kwak, D. S., Park, Y. Y., Chang, Y., Huh, J. W., Lim, C., Koh, Y., Song, D., & Hong, S. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.05.003 · Cited by 75
Radu, C. G., Cheng, D., Nijagal, A., Riedinger, M., McLaughlin, J., Yang, L. V., Johnson, J., & Witte, O. N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.668-677.2006 · Cited by 74
Self-citationvan der Kleij, D., van den Biggelaar, A. H. J., Kruize, Y. C. M., Retra, K., Fillié, Y. E., Schmitz, M. G. J., Kremsner, P. G., Tielens, A. G. M., & Yazdanbakhsh, M. (2004) · The Journal of Infectious Diseases · doi:10.1086/382089 · Cited by 73
Rikitake, Y., Hirata, K., Yamashita, T., Iwai, K., Kobayashi, S., Itoh, H., Ozaki, M., Ejiri, J., Shiomi, M., Inoue, N., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040598.18570.54 · Cited by 73
Kumar, S. U., Kumar, D. T., Ramamoorthy, S., Doss, C. G. P., Younes, S. N., Younes, N., Sidenna, M., & Zayed, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00276 · Cited by 71
Kilaru, A., & Chapman, K. D. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190086 · Cited by 81
Experimental Therapeutic Strategies for Severe Sepsis
Parrish, W. R., Gallowitsch‐Puerta, M., Czura, C. J., & Tracey, K. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.011 · Cited by 68
Apoptotic Cells at the Crossroads of Tolerance and Immunity
Škoberne, M., Beignon, A., Larsson, M., & Bhardwaj, N. (2005) · Springer eBooks · doi:10.1007/3-540-27320-4_12 · Cited by 69
Scientific and Clinical Challenges in Sepsis
Ulloa, L., Brunner, M., Ramos, L., & Deitch, E. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453248 · Cited by 66
Natural products as mediators of disease
Garg, N., Luzzatto‐Knaan, T., Melnik, A. V., Caraballo‐Rodríguez, A. M., Floros, D. J., Petras, D., Gregor, R., Dorrestein, P. C., & Phelan, V. V. (2016) · Natural Product Reports · doi:10.1039/c6np00063k · Cited by 70
Evolution of acid nociception: ion channels and receptors for detecting acid
Pattison, L. A., Callejo, G., & Smith, E. S. J. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0291 · Cited by 73
Lysophosphatidylcholine induces glial cell activation: Role of rho kinase
Sheikh, A. M., Nagai, A., Ryu, J. K., McLarnon, J. G., Kim, S. U., & Masuda, J. (2008) · Glia · doi:10.1002/glia.20815 · Cited by 66
Lawson, B. R., Baccalà, R., Song, J. J., Croft, M., Kono, D. H., & Theofilopoulos, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031685 · Cited by 65
The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
Hohmann, S. W., Angioni, C., Tunaru, S., Lee, S., Woolf, C. J., Offermanns, S., Geißlinger, G., Scholich, K., & Sisignano, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-00591-0 · Cited by 64
Heterotrimeric G protein signaling: Role in asthma and allergic inflammation
Johnson, E. N., & Druey, K. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122636 · Cited by 63
Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132
Lahvic, J. L., Ammerman, M., Li, P., Blair, M. C., Stillman, E., Fast, E. M., Robertson, A. L., Christodoulou, C., Perlin, J. R., Yang, S. P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806077115 · Cited by 62
Kostenis, E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.005 · Cited by 61
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
Cheng, W. Y., Huynh, H., Chen, P., Peña‐Llopis, S., & Wan, Y. (2016) · eLife · doi:10.7554/elife.18501 · Cited by 60
Efferocytosis in the Central Nervous System
Zhao, J., Zhang, W., Wu, T., Wang, H., Mao, J., Liu, J., Zhou, Z., Lin, X., Yan, H., & Wang, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.773344 · Cited by 57
Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis
Cho, W. H., Park, T., Park, Y.-Y., Huh, J. W., Lim, C., Koh, Y., Song, D., & Hong, S.-B. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1505-6 · Cited by 57
The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity
Wang, D. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1434792 · Cited by 57
Sphingosine 1-phosphate pathway therapeutics: a lipid ligand–receptor paradigm
Rosen, H., & Liao, J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00085-1 · Cited by 57
NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
Brosseau, J., Liao, C.-P., Wang, Y., Ramani, V., Vandergriff, T. W., Lee, M., Patel, A., Ariizumi, K., & Le, L. Q. (2018) · Nature Communications · doi:10.1038/s41467-018-07452-y · Cited by 56
Self-citationLe, L. Q., Kabarowski, J. H. S., Wong, S., Nguyen, K., Gambhir, S. S., & Witte, O. N. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00058-2 · Cited by 56
Self-citationDiscovery of new G protein-coupled receptors for lipid mediators
Im, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300006-jlr200 · Cited by 57
Emo, J. A., Meednu, N., Chapman, T. J., Rezaee, F., Balys, M. M., Randall, T. D., Rangasamy, T., & Georas, S. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102956 · Cited by 56
Redirection of B cell responsiveness by transforming growth factor β receptor
Roes, J., Choi, B. K., & Cazac, B. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0731875100 · Cited by 53
Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells
Rubenfeld, J., Guo, J., Sookrung, N., Chen, R., Chaicumpa, W., Casolaro, V., Zhao, Y., Natarajan, V., & Georas, S. N. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00473.2004 · Cited by 53
The Push-Me Pull-You of T Cell Activation
Carson, M. J., & Lo, D. D. (2001) · Science · doi:10.1126/science.1063516 · Cited by 53
Kern, K., Schäfer, S. M. G., Cohnen, J., Pierre, S. C., Osthues, T., Tarighi, N., Hohmann, S., Ferreirós, N., Brüne, B., Weigert, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02261 · Cited by 55
Takenouchi, T., Sato, M., & Kitani, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04570.x · Cited by 51
Munoz, L. E., Peter, C., i, M. H., Wesselborg, S., & Lauber, K. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.11.016 · Cited by 52
Metadata
- Authors
- Le, L. Q., Kabarowski, J. H. S., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., Miller, J. F., & Witte, O. N.
- Affiliations
- University of California, Los Angeles (US)
- The University of Texas Southwestern Medical Center (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Witte, Owen N
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 14
- Issue
- 5
- Pages
- 561-571
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2095533402
- Cited by
- 215
- References
- 50
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 7
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca076204-05)
- National Cancer Institute (CA76204, T32 CA090576)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- G2A, orphan G protein-coupled receptor, knockout mice, lymphocyte homeostasis, B cell hyperactivation, cachexia, immune complex deposition, antinuclear antibodies, aging
- MeSH terms
- Animals, Autoimmune Diseases, B-Lymphocytes, Cell Division, Female, Lymph Nodes, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Antigen, T-Cell, Receptors, Cell Surface, T-Lymphocytes, Time Factors, Autoimmunity, Mice, Knockout, Cell Cycle Proteins, GTP-Binding Proteins, Receptors, G-Protein-Coupled, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review